Skip to main content

Together we are beating cancer

Donate now

Research policy

Showing 12 out of 97 results
Chancellor of the Exchequer Jeremy Hunt leaves 11 Downing Street, London, with his ministerial box before delivering his Budget in the Houses of Parliament

We've waded through the wealth of announcements and numbers in yesterday's budget to summarise some of the key points for what this budget means for our mission to beat cancer. We've waded through the wealth of announcements and numbers in yesterday's budget to summarise some of the key points for what this budget means for our mission to beat cancer.

by Ian Caleb | Analysis | 7 March 2024

7 March 2024

A scientist carrying out clinical research in the lab.

Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS. Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS.

by Joe Kiely | Opinion | 12 February 2024

12 February 2024

the Palace of Westminster

Here are our initial thoughts on what the 2023 autumn statement means for the UK's cancer research environment.   Here are our initial thoughts on what the 2023 autumn statement means for the UK's cancer research environment.  

by Cancer Research UK | News | 22 November 2023

22 November 2023

Two cancer researchers looking at a cell image on screen

The UK is rejoining Horizon Europe, the EU’s £81bn flagship funding scheme for scientific research. The agreement will bring more funding for cancer researchers in the UK, as well as more opportunities for collaboration across Europe. The UK is rejoining Horizon Europe, the EU’s £81bn flagship funding scheme for scientific research. The agreement will bring more funding for cancer researchers in the UK, as well as more opportunities for collaboration across Europe.

by Tim Gunn | News | 7 September 2023

7 September 2023

An illustration of Europe seen from space, with blue beams representing communication between countries

Cancer Research UK is calling on the UK and EU to close the deal on association to Horizon Europe, saying that it is in the best interests of cancer researchers and people affected by cancer.  Cancer Research UK is calling on the UK and EU to close the deal on association to Horizon Europe, saying that it is in the best interests of cancer researchers and people affected by cancer. 

by Jacob Smith | News | 25 August 2023

25 August 2023

Big Ben and Westminster

With budgets being squeezed by inflation, Jeremy Hunt announced measures to increase tax intakes and put a lid on public spending. But what does it mean for people affected by cancer?  With budgets being squeezed by inflation, Jeremy Hunt announced measures to increase tax intakes and put a lid on public spending. But what does it mean for people affected by cancer? 

by Matt Sample | Opinion | 17 November 2022

17 November 2022

Ian Walker

When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications. When the economy faces a slump, investing in research becomes an urgent priority, writes Dr Ian Walker, our executive director of policy, information and communications.

by Ian Walker | Opinion | 16 November 2022

16 November 2022

  • For Researchers
  • Health & Medicine
  • Science & Technology

Why diversity in STEM is vital to cancer research

Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research… Cancer Research UK has an important role in fostering a diverse and inclusive research environment, and here we give a brief summary of our response to the consultation and explain why this matters for cancer research…

by Cancer Research UK | Analysis | 3 March 2022

3 March 2022

This entry is part 4 of 8 in the series Diversity in research